Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Praveen Oberai

Praveen Oberai

Central Council for Research in Homoeopathy, India.

Title: A prospective multi-centric open clinical trial of homeopathy in diabetic distal symmetric polyneuropathy

Biography

Biography: Praveen Oberai

Abstract

Objectives: To evaluate homeopathic treatment in the management of diabetic distal symmetric polyneuropathy.

Methods: A prospective multi-centric clinical observational study was carried out from October 2005 to September 2009 by Central Council for Research in Homeopathy (CCRH) (India) at its five institutes/units. Patients suffering from diabetes mellitus (DM) with symptoms of diabetic polyneuropathy (DPN) were screened, investigated and enrolled after fulfilling inclusion/exclusion criteria. Patients were evaluated by the Diabetic Distal Symmetric Polyneuropathy Symptom Score (DDSPSS) developed by the Council. A total of 15 homeopathic medicines were identified after repertorizing the nosological symptoms and signs of the disease. The appropriate constitutional medicine was selected and prescribed in 30, 200 and 1 M potency on an individualized basis. Patients were followed up regularly for 12 months.

Results: Out of 336 patients enrolled in the study, 247 patients were analyzed. All patients who attended at least three follow-up appointments and baseline curve conduction studies were included in the analysis. A statistically significant improvement in DDSPSS total score (p=0.0001) was found at 12 months from baseline. Lycopodium clavatum (n=132), Phosphorus (n=27) and Sulphur (n=26) were the medicines most frequently prescribed. Adverse event of hypoglycemia was observed in one patient only.

Conclusion: This study suggests homeopathic medicines may be effective in managing the symptoms of DPN patients. Further studies should be controlled and include the Quality of Life (QOL) assessment.